AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

NCT00003759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: BCG vaccine
DRUG: valrubicin
PROCEDURE: conventional surgery

Sponsor

Anthra Pharmaceuticals